Highly portable quantitative screening test for prostate-specific antigen at point of care
Prostate cancer (PCa) is the second most diagnosed cancer among men. Targeted PCa screening may decrease PCa-specific mortality. Prostate-specific antigen (PSA) is the most reliable and widely accepted tumor biomarker for screening and monitoring PCa status. However, in many settings, quantification...
Guardado en:
Autores principales: | Balaji Srinivasan, David M. Nanus, David Erickson, Saurabh Mehta |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/73b22ced6c0e487ab6c08edf45a1f912 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prostate-Specific Antigen and Testosterone Levels as Biochemical Indicators of Cognitive Function in Prostate Cancer Survivors and the Role of Diabetes
por: Alicja Popiołek, et al.
Publicado: (2021) -
Towards personalized prostate cancer screening
por: Filella Xavier
Publicado: (2020) -
Prospective investigation of change in the prostate-specific antigens after various urologic procedures
por: Park SC, et al.
Publicado: (2015) -
Possible association between periodontitis and prostatitis: A pilot study
por: Stefanovska Emilija S., et al.
Publicado: (2021) -
Cambios recientes en la mortalidad por cáncer de próstata en Chile: estudio de tendencias en el período 1955-2001
por: Vives V,Alejandra, et al.
Publicado: (2004)